Haploidentical stem cell transplant: donor choice, preparation and recovery

What half-matched means

HLA markers help the immune system recognize cells. A haploidentical donor shares one of the patient's inherited sets of these markers. The match is assessed by laboratory HLA testing; family relationship or blood group alone cannot establish suitability.

Potential family donors need their own medical assessment. A transplant team compares available donors and cell sources in the context of the patient's disease and protocol. Finding a willing relative is a useful beginning, followed by testing and an individual discussion of donation.

Sources and references: [1]

First establish why transplant is being considered

An allogeneic transplant can replace blood-forming cells and provide an immune effect against some blood cancers. It may be discussed for selected leukemias, lymphomas and other disorders. The reason for transplant and the current disease response shape its timing.

Ask what advantage transplant is expected to offer over continued drug treatment and what needs to happen before it proceeds. A patient whose disease requires further control has a different immediate plan from someone already ready for conditioning. These questions should be settled before travel arrangements become fixed.

Sources and references: [2]

How the donor assessment is organized

The team considers the available HLA matches, donor health and the urgency of treatment. Recipient antibodies directed against donor HLA can complicate selection, so antibody testing may be needed. The choice is made with the graft-versus-host disease prevention strategy in mind.

Ask which relatives should be tested first and whether a registry search should run alongside family testing. It is useful to clarify the expected collection method and whether the donor needs to be present for more than one assessment visit. Donor consent and medical decisions belong to the donor's clinical team.

Sources and references: [3]

The treatment before the cells are infused

Conditioning uses chemotherapy, sometimes with radiation, to prepare for the donor cells and treat the underlying disease. Its intensity is adapted to the disease and the patient's health. Reduced-intensity conditioning can be considered in some settings, but the full transplant still requires substantial care.

Before conditioning, the team checks organ function and infection status and discusses fertility where appropriate. Ask for a written sequence from admission through cell infusion and early recovery. Include what could postpone the start, such as an infection or a change in disease status.

Sources and references: [2]

Preventing and recognizing graft-versus-host disease

Donor immune cells can attack the recipient's healthy tissues, causing graft-versus-host disease. Prevention medicines are part of the protocol. The exact combination and timing vary with the transplant approach. These medicines also affect immune recovery and infection risk.

After discharge, new rash, persistent diarrhea, jaundice or other changes need prompt discussion with the transplant team. Do not adjust immune-suppressing medicines without its instructions. Ask how the service handles urgent symptoms at night and which local hospital can provide assessment if you are away from the transplant center.

Sources and references: [2]

What early recovery requires

The period before healthy blood production recovers can involve low counts, transfusions, infection treatment and close laboratory monitoring. Mouth soreness, nausea or poor intake may add to the burden. Recovery is assessed with blood results and the overall clinical picture.

Have a caregiver plan that includes transport, medicines and communication with the team. Ask what help will be needed after discharge and how near the transplant center you should stay. The clinical team should set the timetable for leaving the area and for any long journey.

Sources and references: [2]

Plan the handover before returning home

Immune recovery takes time, and follow-up extends well beyond the cell infusion. The plan can include infection prevention, vaccination at the appropriate stage and monitoring for relapse or transplant complications. The home clinician needs a clear account of the transplant and current medicines.

Request a discharge summary with donor and graft details, complications, laboratory targets and contact information for urgent questions. Ask who will interpret results after you return home. A written shared-care plan can reduce uncertainty when symptoms arise far from the original center.

Sources and references: [2]

Preparing a transplant inquiry in Shanghai

A Shanghai hematology inquiry can begin through a relevant service such as Ruijin Hospital. The transplant team must confirm the appropriate pathway, donor evaluation and case-specific requirements. Bring the diagnosis, treatment response, organ assessments and any HLA results already available.

EastMedGo can help organize the administrative inquiry and clarify the records requested. Once the clinical service outlines a feasible assessment pathway, we can discuss visit planning, caregiver logistics and coordination costs. Donor medical assessment and the transplant decision remain with the responsible clinical teams.

Sources and references: [4]

Common questions